Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Never Fully Enforced The Clozapine REMS. Now’s It’s Not Needed
Feb 27 2025
•
By
Sue Sutter
A patient advocacy group said the elimination of the REMS is the first domino to fall in improving clozapine access.
(Shutterstock)
More from Drug Safety
More from Geography